Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial
一项多中心、随机、双盲、安慰剂对照、多组、多阶段试验的研究方案，旨在评估螺内酯和泛昔洛韦治疗进行性多发性硬化症以预防残疾进展的疗效：STOP-MS试验
期刊:BMJ Neurology Open
影响因子:2.4
doi:10.1136/bmjno-2025-001313
Ward, Kayla; Li, Vivien; Ramanathan, Sudarshini; Hall, Lesley-Ann; Buzzard, Katherine; Young, Kaylene; Mckay, Fiona; Vigar, Vanessa; Oishi, Sabrina; Madrid San Martin, Lidia; Kaskow, Belinda; Parnell, Grant; Campbell, Julie A; Sun, Jing; Smith, Corey; Jokubaitis, Vilija; Kalincik, Tomas; Tscharke, David; Potter, Andrew; Brady, Erin; Lechner-Scott, Jeannette; Steinman, Lawrence; Parmar, Mahesh; Chataway, Jeremy; Hardy, Todd; Carroll, William M; Barnett, Michael H; Taylor, Bruce V; Broadley, Simon A
